2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Long-term Follow Up on TILs in Metastatic Melanoma: Is Lifileucel Effective in Refractory Disease?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Adil Daud
By 2020 ASCO Virtual Direct™ Highlights FEATURING Adil Daud
73 views
August 24, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin
Skin
07:47
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Melanoma: Does Triplet Regimen Improve …

Feat. A. Daud
07:25
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Melanoma: Is There a Significant Antitumor Activ…

Feat. A. Daud
09:06
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Long-term Follow Up on TILs in Metastatic Melanoma: Is Lif…

Feat. A. Daud
07:41
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on IO in Metastatic Melanoma: Is the Addition of Ip…

Feat. A. Daud